Keywords: update, fda, panel, votes, favor, outcomes, over

UPDATE: FDA panel votes in favor of outcomes over surrogate markers in diabetes drug approval

Article | 07 July 2008

Print This

A US Food and Drug Administration advisory panel has recommended raising the bar to the approval of diabetes drugs by ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in